| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.0M | -60.8% |
| R&D Expense | $319.1M | -3.3% |
| SG&A Expense | $76.6M | +2.2% |
| Operating Income | -$372.5M | +0.1% |
| Income Tax | $0 | — |
| Net Income | -$337.7M | +1.2% |
| EPS (Basic) | -$2.36 | +15.4% |
| EPS (Diluted) | -$2.36 | +15.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $124.3M | -13.5% |
| Current Assets | $809.2M | +5.1% |
| Total Assets | $871.3M | +3.2% |
| Current Liabilities | $50.7M | +67.6% |
| Total Liabilities | $93.5M | +1.7% |
| Stockholders' Equity | $777.8M | +3.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$249.1M | +17.1% |
| Capital Expenditures | $2.0M | -51.1% |
| Investing Cash Flow | -$41.1M | -115.9% |
| Financing Cash Flow | $270.2M | +677.4% |
| Free Cash Flow | -$251.1M | +17.5% |